Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Jinxin Fertility Group Ltd. ( (HK:1951) ) has provided an update.
Jinxin Fertility Group Ltd. announced a change in its board composition with the resignation of Mr. Fang Min as a non-executive director and his replacement by Mr. Shuyun Chen, effective immediately. Mr. Chen brings extensive experience from his previous roles in investment and healthcare sectors, which could enhance the company’s strategic direction and governance.
The most recent analyst rating on (HK:1951) stock is a Buy with a HK$3.80 price target. To see the full list of analyst forecasts on Jinxin Fertility Group Ltd. stock, see the HK:1951 Stock Forecast page.
More about Jinxin Fertility Group Ltd.
Jinxin Fertility Group Ltd. operates in the healthcare industry, focusing on fertility services. The company is involved in providing specialized medical services related to fertility and reproductive health.
Average Trading Volume: 89,960,775
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$7.71B
For a thorough assessment of 1951 stock, go to TipRanks’ Stock Analysis page.